Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Important advances have been made in the past 15 years in the treatment and outcomes for peripartum cardiomyopathy (PPCM) subjects. Despite that, PPCM remains one of the leading causes of maternal mortality all over the world and for those who survive too many are still left with a chronic cardiomyopathy of varying severity. Recent reports in the medical literature document the advances. This report emphasizes three important needs for the advancement of understanding and outcomes for PPCM.